| Device Classification Name |
Antiserum, Coagglutination (Direct) Neisseria Gonorrhoeae
|
| 510(k) Number |
K911430 |
| Device Name |
IDEIA(TM) CHLAMYDIA, MODIFICATION |
| Applicant |
| Novo Nordisk Diagnostics, Ltd. |
| Dirac House, St. John'S |
| Innovation Park, Cowley Rd. |
|
Cambridge Cb4 4ws England,
GB
|
|
| Applicant Contact |
STEPHEN A ABBOTT |
| Correspondent |
| Novo Nordisk Diagnostics, Ltd. |
| Dirac House, St. John'S |
| Innovation Park, Cowley Rd. |
|
Cambridge Cb4 4ws England,
GB
|
|
| Correspondent Contact |
STEPHEN A ABBOTT |
| Regulation Number | 866.3390 |
| Classification Product Code |
|
| Date Received | 03/28/1991 |
| Decision Date | 08/07/1991 |
| Decision |
Substantially Equivalent
(SESE) |
| Regulation Medical Specialty |
Microbiology
|
| 510k Review Panel |
Microbiology
|
| Type |
Traditional
|
| Reviewed by Third Party |
No
|
| Combination Product |
No
|
Predetermined Change Control Plan Authorized |
No
|
|
|